X0306 4 2015-02-13 0 0001596783 Catalent, Inc. CTLT 0001612230 Houlton Scott C/O CATALENT, INC. 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873 0 1 0 0 See Remarks Common Stock 2015-02-13 4 M 0 3293 10.71 A 21574 D Common Stock 2015-02-13 4 F 0 1893 28.28 D 19.681 D Common Stock 2015-02-13 4 S 0 1400 28.28 D 18281 D Common Stock 2015-02-17 4 M 0 31210 10.71 A 49491 D Common Stock 2015-02-17 4 F 0 18.072 27.42 D 31419 D Common Stock 2015-02-17 4 S 0 13138 27.42 D 18281 D Options to purchase common stock 10.71 2015-02-13 4 M 0 3293 0 A 2010-10-23 2019-10-23 Common Stock 3293 25967 D Options to purchase common stock 10.71 2015-02-17 4 M 0 31210 0 A 2010-10-23 2019-10-23 Common Stock 31210 56290 D Represents shares withheld to pay the exercise price and applicable withholding taxes associated with the exercise of stock options. These shares were sold in multiple transactions at prices ranging from $28.00 to $28.72, inclusive. The reporting person undertakes to provide to Catalent, Inc., any security holder of Catalent, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. These shares were sold in multiple transactions at prices ranging from $27.30 to $27.47, inclusive. The reporting person undertakes to provide to Catalent, Inc., any security holder of Catalent, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. On October 23, 2009, the reporting person was granted an option to purchase 29,260 shares of common stock of the Issuer which vest and become exercisable in five equal annual installments based on satisfaction of certain performance criteria for each of the fiscal years ending 2010, 2011, 2012, 2013 and 2014. The performance criteria for 2010, 2011, 2012, 2013 and 2014 were met. On October 23, 2009, the reporting person was granted an option to purchase 87,500 shares of common stock of the Issuer, which vest and become exercisable in five equal annual installments beginning on October 23, 2010. President, Development & Clinical Services Christine Caputo, by power of attorney 2015-02-18